Profusa, Inc. Files 8-K
Ticker: NVACW · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1859807
| Field | Detail |
|---|---|
| Company | Profusa, INC. (NVACW) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financial-reporting
TL;DR
Profusa Inc. filed an 8-K on Oct 20, 2025, for Reg FD disclosure & exhibits.
AI Summary
Profusa, Inc. filed an 8-K on October 21, 2025, reporting an event on October 20, 2025. The filing is categorized under Regulation FD Disclosure and Financial Statements and Exhibits. Profusa, Inc., formerly NorthView Acquisition Corp, is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry.
Why It Matters
This 8-K filing indicates Profusa, Inc. is making a regulatory disclosure and submitting financial exhibits, which could signal significant business developments or financial reporting updates.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not inherently present immediate financial risk.
Key Players & Entities
- Profusa, Inc. (company) — Registrant
- NorthView Acquisition Corp (company) — Former company name
- October 20, 2025 (date) — Date of earliest event reported
- October 21, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 3841 (sic_code) — Standard Industrial Classification
FAQ
What is the primary purpose of this 8-K filing by Profusa, Inc.?
The filing is for Regulation FD Disclosure and Financial Statements and Exhibits, with the earliest event reported on October 20, 2025.
When was Profusa, Inc. incorporated and what is its principal executive office address?
Profusa, Inc. is incorporated in Delaware and its principal executive offices are located at 626 Bancroft Way, Suite A, Berkeley, CA 94710.
What was Profusa, Inc.'s former name and when did the name change occur?
Profusa, Inc.'s former name was NorthView Acquisition Corp, and the date of the name change was April 29, 2021.
What is Profusa, Inc.'s SIC code and industry classification?
Profusa, Inc. has a Standard Industrial Classification code of 3841, which falls under Surgical & Medical Instruments & Apparatus.
What is the filing date and the date of the earliest event reported in this 8-K?
The filing date is October 21, 2025, and the date of the earliest event reported is October 20, 2025.
Filing Stats: 592 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2025-10-20 17:51:33
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PFSA The Nasdaq Stock Mar
Filing Documents
- ea0261836-8k_profusa.htm (8-K) — 27KB
- ea026183601ex99-1_profusa.htm (EX-99.1) — 37KB
- ex99-1_001.jpg (GRAPHIC) — 619KB
- ex99-1_002.jpg (GRAPHIC) — 1144KB
- ex99-1_003.jpg (GRAPHIC) — 715KB
- ex99-1_004.jpg (GRAPHIC) — 483KB
- ex99-1_005.jpg (GRAPHIC) — 922KB
- ex99-1_006.jpg (GRAPHIC) — 437KB
- ex99-1_007.jpg (GRAPHIC) — 533KB
- ex99-1_008.jpg (GRAPHIC) — 855KB
- ex99-1_009.jpg (GRAPHIC) — 436KB
- ex99-1_010.jpg (GRAPHIC) — 617KB
- ex99-1_011.jpg (GRAPHIC) — 526KB
- ex99-1_012.jpg (GRAPHIC) — 449KB
- ex99-1_013.jpg (GRAPHIC) — 486KB
- ex99-1_014.jpg (GRAPHIC) — 435KB
- ex99-1_015.jpg (GRAPHIC) — 488KB
- ex99-1_016.jpg (GRAPHIC) — 667KB
- ex99-1_017.jpg (GRAPHIC) — 418KB
- ex99-1_018.jpg (GRAPHIC) — 452KB
- ex99-1_019.jpg (GRAPHIC) — 398KB
- ex99-1_020.jpg (GRAPHIC) — 728KB
- ex99-1_021.jpg (GRAPHIC) — 630KB
- ex99-1_022.jpg (GRAPHIC) — 586KB
- 0001213900-25-100443.txt ( ) — 18179KB
- nvacw-20251020.xsd (EX-101.SCH) — 3KB
- nvacw-20251020_lab.xml (EX-101.LAB) — 33KB
- nvacw-20251020_pre.xml (EX-101.PRE) — 22KB
- ea0261836-8k_profusa_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On October 20, 2025, Profusa, Inc. (the " Company ") published an updated investor presentation to its website (the " Investor Presentation "). The Company may use the Investor Presentation, possibly with modifications, in presentations from time to time thereafter to current and potential investors, analysts, lenders, business partners, customers, employees and others with an interest in the Company and its business. The Investor Presentation contains forward-looking and the risks and uncertainties related thereto. A copy of the Investor Presentation is attached hereto as Exhibit 99.1. The information provided in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. Such information shall not be deemed incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as otherwise expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 99.1 Investor Presentation, dated October 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 20, 2025 Profusa, Inc. By: /s/ Ben Hwang Name: Ben Hwang Title: Chief Executive Officer 2